Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001615774-17-001494

Options or other derivatives

  • Chief Financial Officer acquired 15,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
D'Ambrosio Donald Eric Chief Financial Officer 2017-03-31 Grant or award · Employee Stock Option (right to purchase) +15,000 15,000 D: show line 1 in the form
Loading xslF345X03/s105793_form4.xml…